Table 2.
Comparison of levels of hyaluronic acid, hydroxyproline and transforming growth factor β1 in liver homogenates
Group | n | HA (ng/g) | Hyp (μg/g) | TGF-β1 (μg/g) |
A | 15 | 1449.93 ± 121.89 | 318.20 ± 9.71 | 284.20 ± 18.32 |
B | 13 | 8803.30 ± 200.57b | 617.77 ± 8.52b | 736.30 ± 24.40b |
C | 15 | 7558.40 ± 161.88bd | 530.27 ± 11.88bd | 651.13 ± 15.75bd |
D | 14 | 5249.21 ± 111.92bdf | 490.00 ± 8.13bdf | 523.14 ± 21.29bdf |
E | 15 | 4050.73 ± 122.18bdfh | 464.07 ± 13.09bdfh | 441.86 ± 23.18bdfh |
Data are expressed as mean ± SD. A: Normal group; B: Model group; C: Natural recovery group; D: Low dose Danshao Huaxian capsule (DHC) treated group; E: High dose DHC treated group.
P < 0.01 vs group A;
P < 0.01 vs group B;
P < 0.01 vs group C;
P < 0.01 vs group D.